News|Articles|March 2, 2003

Pharmaceutical Technology

  • Pharmaceutical Technology-03-02-2003
  • Volume 27
  • Issue 3

Outsourcing Outlook March 2003

Author(s)Jim Miller

CROs and CMOs project strong business operation in 2003, and contract sterile manufacturing companies invest millions to increase capacity.


Related to this article

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.